Health Minister Mansukh Mandaviya launches Bharat Biotech’s nasal Covid vaccine

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech’s nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday.

The world’s first made-in-India intranasal vaccine was launched at Mandaviya’s residence here.

Also Read: No need for fourth dose of COVID-19 vaccine given current evidence: Expert

Also Read

Here’s how lemon juice may help in getting rid of kidney stones

Why Women are more at risk for developing Alzheimer’s or dementia?

Coronavirus in India April 28 Highlights: India vexed over vax! Mumbai shutters down 40 centres due to insufficient stock

Research finds dimming lights few hours before sleep could reduce diabetes risk in pregnant women – Details inside

The nasal vaccine — BBV154 — had received the Drugs Controller General of India’s (DCGI) approval in November for restricted emergency use among adults as a heterologous booster dose.

According to a statement issued by Bharat Biotech earlier, ‘iNCOVACC’ is priced at Rs 800 for private markets and at Rs 325 for supplies to the government of India and state governments iNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.

Also Read: SII seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults

This vaccine candidate was evaluated in phase I, II and III clinical trials with successful results, the Hyderabad-based vaccine maker had said.

Clinical trials were conducted to evaluate iNCOVACC as a primary dose schedule and as a heterologous booster dose for subjects who have previously received two doses of either Covishield or Covaxin. PTI PLB DIV